BCIP Life Sciences Associates, LP, 10% Owner at Xilio Therapeutics, Inc. (XLO), bought 77,739 shares at $9.62 ($748K) on 2021-12-08, disclosed to the SEC on 2021-12-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.62 | 13,458 | $129K | 17.3% |
| 2 | $9.62 | 13,458 | $129K | 17.3% |
| 3 | $9.84 | 4,011 | $39K | 5.3% |
| 4 | $9.56 | 21,812 | $209K | 27.9% |
| 5 | $9.56 | 21,812 | $209K | 27.9% |
| 6 | $10.24 | 3,188 |
| $33K |
| 4.4% |
| Total | $9.62 avg | 77,739 | $748K | 100% |
| Filing → |